DTIC (Dimethyl-Triazeno-Imidazol-Carboxamid)-Dome (Dacarbacin): Nebenwirkungen bei der Behandlung maligner Melanome
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | Undetermined |
| Veröffentlicht: |
1981
|
| Schlagworte: | |
| Beschreibung: | München, Univ., Diss., 1982 |
| Beschreibung: | 86 S. graph. Darst. |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV002296449 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 890928s1981 d||| m||| 00||| und d | ||
| 035 | |a (OCoLC)630678489 | ||
| 035 | |a (DE-599)BVBBV002296449 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | |a und | ||
| 049 | |a DE-20 |a DE-154 | ||
| 100 | 1 | |a Hadulla-Lazica, Barbara |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a DTIC (Dimethyl-Triazeno-Imidazol-Carboxamid)-Dome (Dacarbacin) |b Nebenwirkungen bei der Behandlung maligner Melanome |
| 264 | 1 | |c 1981 | |
| 300 | |a 86 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 500 | |a München, Univ., Diss., 1982 | ||
| 655 | 7 | |0 (DE-588)4113937-9 |a Hochschulschrift |2 gnd-content | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-001509260 | ||
Datensatz im Suchindex
| _version_ | 1804116756837433344 |
|---|---|
| any_adam_object | |
| author | Hadulla-Lazica, Barbara |
| author_facet | Hadulla-Lazica, Barbara |
| author_role | aut |
| author_sort | Hadulla-Lazica, Barbara |
| author_variant | b h l bhl |
| building | Verbundindex |
| bvnumber | BV002296449 |
| ctrlnum | (OCoLC)630678489 (DE-599)BVBBV002296449 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00823nam a2200265 c 4500</leader><controlfield tag="001">BV002296449</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">890928s1981 d||| m||| 00||| und d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)630678489</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV002296449</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">und</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-20</subfield><subfield code="a">DE-154</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Hadulla-Lazica, Barbara</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">DTIC (Dimethyl-Triazeno-Imidazol-Carboxamid)-Dome (Dacarbacin)</subfield><subfield code="b">Nebenwirkungen bei der Behandlung maligner Melanome</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1981</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">86 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">München, Univ., Diss., 1982</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4113937-9</subfield><subfield code="a">Hochschulschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-001509260</subfield></datafield></record></collection> |
| genre | (DE-588)4113937-9 Hochschulschrift gnd-content |
| genre_facet | Hochschulschrift |
| id | DE-604.BV002296449 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T15:43:34Z |
| institution | BVB |
| language | Undetermined |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-001509260 |
| oclc_num | 630678489 |
| open_access_boolean | |
| owner | DE-20 DE-154 |
| owner_facet | DE-20 DE-154 |
| physical | 86 S. graph. Darst. |
| publishDate | 1981 |
| publishDateSearch | 1981 |
| publishDateSort | 1981 |
| record_format | marc |
| spelling | Hadulla-Lazica, Barbara Verfasser aut DTIC (Dimethyl-Triazeno-Imidazol-Carboxamid)-Dome (Dacarbacin) Nebenwirkungen bei der Behandlung maligner Melanome 1981 86 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier München, Univ., Diss., 1982 (DE-588)4113937-9 Hochschulschrift gnd-content |
| spellingShingle | Hadulla-Lazica, Barbara DTIC (Dimethyl-Triazeno-Imidazol-Carboxamid)-Dome (Dacarbacin) Nebenwirkungen bei der Behandlung maligner Melanome |
| subject_GND | (DE-588)4113937-9 |
| title | DTIC (Dimethyl-Triazeno-Imidazol-Carboxamid)-Dome (Dacarbacin) Nebenwirkungen bei der Behandlung maligner Melanome |
| title_auth | DTIC (Dimethyl-Triazeno-Imidazol-Carboxamid)-Dome (Dacarbacin) Nebenwirkungen bei der Behandlung maligner Melanome |
| title_exact_search | DTIC (Dimethyl-Triazeno-Imidazol-Carboxamid)-Dome (Dacarbacin) Nebenwirkungen bei der Behandlung maligner Melanome |
| title_full | DTIC (Dimethyl-Triazeno-Imidazol-Carboxamid)-Dome (Dacarbacin) Nebenwirkungen bei der Behandlung maligner Melanome |
| title_fullStr | DTIC (Dimethyl-Triazeno-Imidazol-Carboxamid)-Dome (Dacarbacin) Nebenwirkungen bei der Behandlung maligner Melanome |
| title_full_unstemmed | DTIC (Dimethyl-Triazeno-Imidazol-Carboxamid)-Dome (Dacarbacin) Nebenwirkungen bei der Behandlung maligner Melanome |
| title_short | DTIC (Dimethyl-Triazeno-Imidazol-Carboxamid)-Dome (Dacarbacin) |
| title_sort | dtic dimethyl triazeno imidazol carboxamid dome dacarbacin nebenwirkungen bei der behandlung maligner melanome |
| title_sub | Nebenwirkungen bei der Behandlung maligner Melanome |
| topic_facet | Hochschulschrift |
| work_keys_str_mv | AT hadullalazicabarbara dticdimethyltriazenoimidazolcarboxamiddomedacarbacinnebenwirkungenbeiderbehandlungmalignermelanome |